These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35477218)

  • 1. Amygdalar CB2 cannabinoid receptor mediates fear extinction deficits promoted by orexin-A/hypocretin-1.
    Ten-Blanco M; Flores Á; Pereda-Pérez I; Piscitelli F; Izquierdo-Luengo C; Cristino L; Romero J; Hillard CJ; Maldonado R; Di Marzo V; Berrendero F
    Biomed Pharmacother; 2022 May; 149():112925. PubMed ID: 35477218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hypocretin/orexin system mediates the extinction of fear memories.
    Flores Á; Valls-Comamala V; Costa G; Saravia R; Maldonado R; Berrendero F
    Neuropsychopharmacology; 2014 Nov; 39(12):2732-41. PubMed ID: 24930888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of brain glucose uptake by cannabinoid CB2 receptors and its therapeutic potential in Alzheimer's disease.
    Köfalvi A; Lemos C; Martín-Moreno AM; Pinheiro BS; García-García L; Pozo MA; Valério-Fernandes Â; Beleza RO; Agostinho P; Rodrigues RJ; Pasquaré SJ; Cunha RA; de Ceballos ML
    Neuropharmacology; 2016 Nov; 110(Pt A):519-529. PubMed ID: 26976670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoids and traumatic stress modulation of contextual fear extinction and GR expression in the amygdala-hippocampal-prefrontal circuit.
    Ganon-Elazar E; Akirav I
    Psychoneuroendocrinology; 2013 Sep; 38(9):1675-87. PubMed ID: 23433741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid CB
    Ivy D; Palese F; Vozella V; Fotio Y; Yalcin A; Ramirez G; Mears D; Wynn G; Piomelli D
    Neuropsychopharmacology; 2020 Jul; 45(8):1330-1338. PubMed ID: 32375160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of endocannabinoids in the hippocampus and amygdala in emotional memory and plasticity.
    Segev A; Korem N; Mizrachi Zer-Aviv T; Abush H; Lange R; Sauber G; Hillard CJ; Akirav I
    Neuropsychopharmacology; 2018 Sep; 43(10):2017-2027. PubMed ID: 29977073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating the role of the amygdala orexin receptor 1 in memory acquisition and extinction in a rat model of PTSD.
    Salehabadi S; Abrari K; Elahdadi Salmani M; Nasiri M; Lashkarbolouki T
    Behav Brain Res; 2020 Apr; 384():112455. PubMed ID: 32044404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the cannabinoid system in fear memory and extinction in male and female mice.
    Mizuno I; Matsuda S; Tohyama S; Mizutani A
    Psychoneuroendocrinology; 2022 Apr; 138():105688. PubMed ID: 35176534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic treatment with URB597 ameliorates post-stress symptoms in a rat model of PTSD.
    Fidelman S; Mizrachi Zer-Aviv T; Lange R; Hillard CJ; Akirav I
    Eur Neuropsychopharmacol; 2018 May; 28(5):630-642. PubMed ID: 29519609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB
    Owens RA; Mustafa MA; Ignatowska-Jankowska BM; Damaj MI; Beardsley PM; Wiley JL; Niphakis MJ; Cravatt BF; Lichtman AH
    Neuropharmacology; 2017 Oct; 125():80-86. PubMed ID: 28673548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Facilitation of Contextual Fear Extinction by Orexin-1 Receptor Antagonism Is Associated with the Activation of Specific Amygdala Cell Subpopulations.
    Flores Á; Herry C; Maldonado R; Berrendero F
    Int J Neuropsychopharmacol; 2017 Aug; 20(8):654-659. PubMed ID: 28453642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The endogenous cannabinoid system controls extinction of aversive memories.
    Marsicano G; Wotjak CT; Azad SC; Bisogno T; Rammes G; Cascio MG; Hermann H; Tang J; Hofmann C; Zieglgänsberger W; Di Marzo V; Lutz B
    Nature; 2002 Aug; 418(6897):530-4. PubMed ID: 12152079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a novel fatty acid binding protein-5-CB2 receptor-dependent mechanism regulating anxiety behaviors in the prefrontal cortex.
    Uzuneser TC; Szkudlarek HJ; Jones MJ; Nashed MG; Clement T; Wang H; Ojima I; Rushlow WJ; Laviolette SR
    Cereb Cortex; 2023 Mar; 33(6):2470-2484. PubMed ID: 35650684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orexins and fear: implications for the treatment of anxiety disorders.
    Flores Á; Saravia R; Maldonado R; Berrendero F
    Trends Neurosci; 2015 Sep; 38(9):550-9. PubMed ID: 26216377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of cannabinoid receptor type 2 attenuates surgery-induced cognitive impairment in mice through anti-inflammatory activity.
    Sun L; Dong R; Xu X; Yang X; Peng M
    J Neuroinflammation; 2017 Jul; 14(1):138. PubMed ID: 28724382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced anandamide signaling reduces flight behavior elicited by an approaching robo-beetle.
    Heinz DE; Genewsky A; Wotjak CT
    Neuropharmacology; 2017 Nov; 126():233-241. PubMed ID: 28890367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CB2 cannabinoid receptor expression is increased in 129S1/SvImJ mice: behavioral consequences.
    Ten-Blanco M; Pereda-Pérez I; Izquierdo-Luengo C; Berrendero F
    Front Pharmacol; 2022; 13():975020. PubMed ID: 36081934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation of OX-1R/CB1R heteromeric complexes in embryonic mouse hypothalamic cells: Effect on intracellular calcium, 2-arachidonoyl-glycerol biosynthesis and ERK phosphorylation.
    Imperatore R; Palomba L; Morello G; Spiezio AD; Piscitelli F; Marzo VD; Cristino L
    Pharmacol Res; 2016 Sep; 111():600-609. PubMed ID: 27436148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tempering aversive/traumatic memories with cannabinoids: a review of evidence from animal and human studies.
    Lisboa SF; Vila-Verde C; Rosa J; Uliana DL; Stern CAJ; Bertoglio LJ; Resstel LB; Guimaraes FS
    Psychopharmacology (Berl); 2019 Jan; 236(1):201-226. PubMed ID: 30604182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guineensine is a novel inhibitor of endocannabinoid uptake showing cannabimimetic behavioral effects in BALB/c mice.
    Nicolussi S; Viveros-Paredes JM; Gachet MS; Rau M; Flores-Soto ME; Blunder M; Gertsch J
    Pharmacol Res; 2014 Feb; 80():52-65. PubMed ID: 24412246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.